Changes in pharmacokinetics. Re- sults of pharmacokinetics measure- ments (i.e., biotransformation, extent of absorption, tissue distribution, and excretion) obtained in rats receiving the single low oral dose of test sub- stance (Group B) shall be compared to the corresponding results obtained in rats receiving repeated oral doses of test substance (Group F).
Appears in 8 contracts
Samples: www.govinfo.gov, www.govinfo.gov, www.govinfo.gov
Changes in pharmacokinetics. Re- sults of pharmacokinetics measure- ments (i.e., biotransformation, bioavailability and extent of absorption, tissue distribution, and excretion) obtained in rats receiving the single low oral dose of the test sub- stance (Group BGroups B and C) shall be compared com- pared to the corresponding results obtained ob- tained in rats receiving repeated oral doses of the test substance (Group F).
Appears in 5 contracts
Samples: www.govinfo.gov, www.govinfo.gov, www.govinfo.gov
Changes in pharmacokinetics. Re- sults of pharmacokinetics measure- ments (i.e., biotransformation, bioavailability and extent of absorption, tissue distribution, and excretion) obtained in rats receiving the single low oral dose of the test sub- stance (Group BGroups B and C) shall be compared com- pared to the corresponding results obtained in rats receiving repeated oral doses of test substance (Group F).ob-
Appears in 2 contracts
Samples: www.govinfo.gov, www.govinfo.gov
Changes in pharmacokinetics. Re- sults of pharmacokinetics measure- ments (i.e., biotransformation, bioavailability and extent of absorption, tissue distribution, and excretion) obtained in rats receiving § 795.231 the single low oral dose of the test sub- stance (Group BGroups B and C) shall be compared com- pared to the corresponding results obtained ob- tained in rats receiving repeated oral doses of the test substance (Group F).
Appears in 1 contract
Samples: www.govinfo.gov
